Age and vaccine information sources drive vaccine hesitancy: A household survey in Central-Western Brazil Authors: Ana Isabel do Nascimento, Danilo dos Santos Conrado, Lisany Krug Mareto, Micael Viana de Azevedo, João Cesar Pereira da Cunha, Gabriel Serrano Ramires Koch, Laysa Gomes Osório, Samara Tessari Pires, Letícia Suemi Arakaki, Sara Raquel Pinto Borges, Robson Franca Gomes e Silva, Rodrigo Mayer Pucci, João Guilherme de Novaes Corrêa, João Vitor Barrio, Maria Eduarda de Souza Rodrigues, Artur Jorge Bianchi, Márcio José de Medeiros, Ana Paula Sayuri Sato, Maria Elizabeth Araújo Ajalla, Cláudia Du Bocage Santos-Pinto, Everton Falcão de Oliveira, Ivan Filipe de Almeida Lopes Fernandes, Ivan Filipe de Almeida Lopes Fernandes, Ivan Filipe de Almeida Lopes Fernandes Published: 2026 ABSTRACT In recent decades, the decline in vaccination coverage has garnered global attention, and the impact of vaccine hesitancy has become a significant concern for public health policymakers worldwide. This study aims to measure vaccine hesitancy and its associated factors among residents of Campo Grande, Mato Grosso do Sul, Brazil. From September 2022 to October 2023, a cross-sectional study aligned with a household survey was conducted to measure vaccination coverage among residents of Campo Grande municipality in Brazil. Data were collected through face-to-face interviews using the WHO. Reasons for vaccine hesitancy were classified under the 3C conceptual model of vaccine hesitancy determinants. Descriptive statistics were employed to characterize the study population, and univariate and multivariate logistic regression analyses were conducted to assess the association between hesitant and non-hesitant participants and the study variables. We included 467 households in the study, with a total of 518 participants interviewed. Over half of the participants hesitated to get vaccinated (50.2%), with the COVID-19 vaccines being the most hesitated (55.4%). The majority of reported reasons for hesitancy were related to a lack of confidence (62.3%). The hesitant participants in our study were younger than the non-hesitant participants (aOR = 0.98; 95% CI: 0.97, 0.99), were less likely to believe that vaccines could protect themselves and their children from serious diseases (aOR = 0.23; 95% CI: 0.06, 0.66), and were less likely to get information from healthcare workers or official health organizations’ online profiles (aOR = 0.39; 95% CI: 0.17, 0.86). We observed a high prevalence of vaccine hesitancy in Campo Grande. The results highlight the potential impact of the COVID-19 pandemic and the infodemic in increasing negative feelings about vaccines. Introduction Vaccination has been recognized as one of the best methods for controlling the transmission of infectious diseases [1]. In Brazil, the Brazilian National Immunization Program (Programa Nacional de Imunizações, PNI), was established as the main institutional strategy for implementing vaccination as a public health policy, building on earlier successful initiatives such as the variola eradication campaign, which aimed to control and eradicate smallpox [2]. This achievement occurred in an adverse national context marked by political instability, limited resources for preventive health measures, and profound social and demographic changes, including rapid urbanization driven by internal migration and persistent sanitation challenges [2]. In response, the Brazilian National Immunization Program (PNI) was formulated in 1973 and formally established in 1975, following the success of the smallpox eradication campaign, to ensure sustained vaccination capacity and strengthen the foundations of the Brazilian Unified Health System, one of the largest public health systems in the world [2,3]. Since its establishment, the PNI has ensured nationwide access to vaccines free of charge, achieving substantial operational and structural advances [3]. These efforts have led to the control of multiple vaccine-preventable diseases, including poliomyelitis, tetanus, and urban yellow fever, and have contributed significantly to reductions in infant mortality across the country [4]. The PNI also developed widely recognized communication strategies, such as partnerships with media figures, mass radio and television campaigns, and the creation of the nationally recognized character Zé Gotinha, which played a key role in the successful control of poliomyelitis [3]. Nevertheless, vaccination coverage has declined globally in recent years [5]. In Brazil, despite historically high coverage levels, a sustained downward trend has been observed since 2016 [6]. This decline has coincided with the growing influence of anti-vaccine discourse, the politicization of vaccination during the COVID-19 pandemic, and the widespread circulation of misinformation in digital environments, factors that may have contributed to increasing mistrust and changes in public perceptions of immunization. Understanding the reasons behind the choice to vaccinate or not – and interpreting these reasons regarding the context and the perceptions about vaccines and illnesses, considering sociodemographic factors – is crucial for sustaining high vaccine demand [7]. This concern led to the development of the concept of “vaccination hesitancy”, a phenomenon declared as one of the global threats to public health in 2019 and broadened the theoretical framework surrounding vaccination attitudes [8]. This concept highlights the diversity within the vaccine-hesitant population, which spans a spectrum from complete acceptance to outright refusal of vaccines. The World Health Organization (WHO) defines, in 2015, vaccination hesitancy as the “delay in acceptance or refusal of vaccines despite the availability of vaccination services” [9,10]. Vaccine hesitancy fundamentally stems from a decision-making process influenced by a variety of factors, summarized in the 3C model of vaccine hesitancy: complacency, confidence, and convenience. Complacency refers to the underestimation of disease risk and the perceived need for vaccination. Confidence-related determinants encompass mistrust in the vaccine, the health system distributing it, its professionals, and the policymakers governing vaccine policies. Lastly, determinants related to convenience involve issues of geographical access, availability, comprehensibility of vaccine-related information, quality of health services, and other access-related obstacles [10]. Subsequently, the 5C conceptual model was developed to incorporate additional behavioral aspects of vaccination, such as collective responsibility and risk calculation [11], alongside the renewal of the conceptual model, the WHO redefined vaccination hesitancy as “a motivational state of being conflicted about or opposed to, getting vaccinated”, which included intentions and willingness [12]. Following the global trend of declining vaccination coverage rates [6], Campo Grande, the capital of Mato Grosso do Sul, located in a tri-border region (Brazil-Bolivia-Paraguay), has experienced a decline in vaccination coverage since 2019 [13]. Based on this context, this study aimed to measure vaccination hesitancy and identify its associated factors among residents of Campo Grande. Materials and methods Study design and period This cross-sectional study used data collected through a household survey conducted in Campo Grande, Mato Grosso do Sul, Brazil, between September 2022 and October 2023, with the primary objective of estimating vaccination coverage in the municipality. For the purposes of this analysis, data on vaccine hesitancy were also collected and analysed. Study site Campo Grande, the capital state of Mato Grosso do Sul, by the time of our study, comprised a population of 898,100 inhabitants. The municipality holds a population mostly female and young (sex ratio = 92.2; age median = 34 years) [14]. Mato Grosso do Sul shares borders with Bolivia and Paraguay, holding, alongside Mato Grosso, over 60% of the immigrant population of the Brazilian Central-West region between 2022 and 2023 [15]. In the same period, Mato Grosso do Sul provided the second-highest amount of refugee concessions in the region. The state received four times the migrant population of 2013 [15]. In 2022, 5,614 migrant workers were received in the municipality [15]. Therefore, healthcare actions to promote vaccination are common in the municipality of Campo Grande, targeting immigrants and refugees. Sampling The sampling method was cluster sampling, according to the one proposed by the WHO, in 2018, for studies that aim to estimate vaccination coverage [16]. Further details of the sampling method and calculation are described in the S1 Appendix. This method is based on two stages: (1) cluster selection and (2) households’ selection. (1)Definition and selection of clusters: Assuming that the expected average vaccination coverage in Campo Grande, for all vaccines available in the PNI, is 90%, with a confidence interval around the estimates of 8% (i.e., 90% ± 8% coverage estimate), with an alpha (type I error) of 5%, the effective sample size – based on an assumption of simple random sampling – was n = 101. To determine the average number of people eligible for the study (individuals aged 12 years or older), a pilot study was conducted. For this, one cluster (census tract) was randomly selected. Considering that on average, in Brazil, each census tract has approximately 300 households, for the pilot study 10% of the households contained in the selected cluster were drawn, which resulted in 31 households. After completing the pilot study, the average number of respondents per cluster, within a 3-hour interval, with a field team of 6 researchers, distributed in pairs, was 10. Assuming that the intracluster correlation is 0.33 [16], the design effect size was set at 3. Applying the formula proposed by the WHO, the estimated number of clusters was 30.3, which was rounded to 30. The selection of clusters was done by simple random sampling without replacement, using the cartographic base of census sectors from the IBGE of 2021. The cluster where the pilot study was conducted was included in the study. Therefore, an additional 29 clusters were sampled afterward. Clusters that primarily contained institutionalized populations (prisons and long-term care facilities, such as nursing homes) were immediately replaced when drawn. Clusters containing large condominiums or gated communities that did not allow the study team entry for data collection after initial contact by the researchers were also replaced. Definition and selection of clusters: Assuming that the expected average vaccination coverage in Campo Grande, for all vaccines available in the PNI, is 90%, with a confidence interval around the estimates of 8% (i.e., 90% ± 8% coverage estimate), with an alpha (type I error) of 5%, the effective sample size – based on an assumption of simple random sampling – was n = 101. To determine the average number of people eligible for the study (individuals aged 12 years or older), a pilot study was conducted. For this, one cluster (census tract) was randomly selected. Considering that on average, in Brazil, each census tract has approximately 300 households, for the pilot study 10% of the households contained in the selected cluster were drawn, which resulted in 31 households. After completing the pilot study, the average number of respondents per cluster, within a 3-hour interval, with a field team of 6 researchers, distributed in pairs, was 10. Assuming that the intracluster correlation is 0.33 [16], the design effect size was set at 3. Applying the formula proposed by the WHO, the estimated number of clusters was 30.3, which was rounded to 30. The selection of clusters was done by simple random sampling without replacement, using the cartographic base of census sectors from the IBGE of 2021. The cluster where the pilot study was conducted was included in the study. Therefore, an additional 29 clusters were sampled afterward. Clusters that primarily contained institutionalized populations (prisons and long-term care facilities, such as nursing homes) were immediately replaced when drawn. Clusters containing large condominiums or gated communities that did not allow the study team entry for data collection after initial contact by the researchers were also replaced. (2)The definition of the number and selection of the households was based on the pilot study. The number of residencies visited to find an eligible participant averaged 1.5, the inflation factor to account for refusals and non-respondent residences was 1.05, and the average number of respondents per day of data collection was 10. Therefore, the number of households per cluster was defined as 15. Those households were selected by random simple probabilistic sampling. The definition of the number and selection of the households was based on the pilot study. The number of residencies visited to find an eligible participant averaged 1.5, the inflation factor to account for refusals and non-respondent residences was 1.05, and the average number of respondents per day of data collection was 10. Therefore, the number of households per cluster was defined as 15. Those households were selected by random simple probabilistic sampling. The random sampling and spatial allocation of clusters and households were performed using sf package from software R 3.4.2. Study population and data collection All residents of the Campo Grande municipality, aged 12 years or more, who consented to participate in this study, were eligible. The study was based on data collected through an interview using the SAGE Work Group questionnaire from 2015, which was translated into Portuguese and linguistically adapted to fit our context, without deviating from its original meaning [9,10,17]. Questions about socioeconomic and demographic variables, along with access to health units with vaccination facilities, were included in this interview and data collection instrument. During the interviews, participants were informed about the concept of vaccination hesitancy, proposed by the WHO in 2015, since this study’s instrument was developed based on that definition [10], and answered about the vaccine hesitancy related to their own vaccination and their reasons for the hesitation. Finally, we classified the reasons for hesitancy under the 3C conceptual model for vaccine hesitancy, as the data collection questionnaire that we used was built based on this model (S3 Appendix). When possible, these reasons were also interpreted in light of the ‘risk calculation’ dimension (the individual assessment of the risks and benefits of vaccination) from the 5C model of vaccine hesitancy [11]. Statistical analysis Descriptive statistics was employed to characterize the studied population. The study data were analysed according to the occurrence of vaccine hesitancy. Therefore, the study population was divided into hesitant (HP) and non-hesitant (NHP) participants. The continuous variables were reported as mean values and standard deviation (SD) and were compared with the Welch t-test. The categorical variables were reported as a frequency and were compared with the chi-square and/or Fisher’s exact tests in this stage. We conducted a multivariate logistic regression model to assess the relationship between vaccine hesitancy and the covariates found to have a p-value of 0.20 or less were included in the previous stage of the analysis. The stepwise algorithm (considering both backward and forward directions) and the Akaike Information Criterion (AIC) were used for variable selection, controlling for potential confounders, and determining the best-fitting model. The presence of multicollinearity was assessed using the variance inflation factor (VIF). The Hosmer-Lemeshow test was used as a measure of fit. To explore heterogeneity across age groups, we conducted additional analyses using categorized age. Age was grouped into 20-year intervals to ensure sufficient sample size within each category. Descriptive analyses compared the distribution of vaccine hesitancy across age groups, and a multivariable logistic regression model was re-estimated using age as a categorical variable, applying the same modelling strategy as in the primary analysis (see S2 Appendix). This complementary approach was adopted to facilitate interpretation of potential generational patterns, while age was retained as a continuous variable in the main model to preserve statistical power. The significance level adopted for all hypothesis tests was 5% (α = 0.05). The analysis was performed using R software version 4.3.2 (https://www.r-project.org/), and the following packages were used: tidyverse, descr, and generalhoslem. Ethics approval and consent to participate The study was approved by the Research Ethics Committee (CEP) of the Federal University of Mato Grosso do Sul (CAEE: 47947821.0.0000.0021), according to opinion nº: 5.200.726. All the participants signed a written informed consent form before the data collection. When adults the Informed Consent Form (ICF) was applied, and the Assent Form (AF) was applied for minors (under 18 years old), along with the consent of the responsible guardian present during the application of the questionnaire, who also signed the ICF. Results A total of 467 households were included and 518 participants were interviewed. The medium of respondents was 1,1 (SD = 0.38) per household, and 17 respondents per cluster (SD = 4). Most of the participants were female (321/518; 62.0%), and non-white (362/518; 69.9%). The mean age of the population was 46,7 years, most participants were between 52–71 (179/518; 34.6%), and 32–51 years old (174/518; 33.6%). The mean of years of study was 9.7. Most of the respondents were not classified as low income (334/518; 64,5%), and the resided households had an average of 3.1 residents per household. Most participants lived in houses with access to piped water (494/518; 95.4%), and sanitary sewer treatment (273/518; 52.7%), but the majority didn’t have health insurance (363/518; 70.1%). The socioeconomics and demographic characteristics of the participants of the study are presented in Table 1. 10.1371/journal.pone.0348412.t001Table 1Study data according to the occurrence of vaccine hesitancy.Total (n= 518)NHP (n = 258)HP (n = 260)OR [95% CI]p-valueAge (mean, (DP))46.7 (17.4)49.6 (18.0)43.8 (16.3)0.98 [0.97; 0.99]<0.001Years of study (mean, (DP))9.7 (4.6)9.5 (4.6)9,9 (4.6)1.02 [0.98;1.06]0.297Residents per household (mean, (DP))3.1 (1.5)3.0 (1.5)3,1 (1.5)1.06 [0.94;1.19]0.304Sex n (%) n (%) Female321 (62.0%)158 (61.2%)163 (62.7%)Reference0.803 Male197 (38.0%)100 (38.8%)97 (37.3%)0.94 [0.66;1.34]Ethnicity White156 (30.1%)74 (28.7%)82 (31.5%)Reference0.540 Non-white362 (69.9%)184 (71.3%)178 (68.5%)0.87 [0.60;1.27]Low income Yes184 (35.5%)88 (34.1%)96 (36.9%)Reference0.564 No334 (64.5%)170 (65.9%)164 (63.1%)0.88 [0.62;1.27]Access to piped water Yes494 (95.4%)248 (96.1%)246 (94.6%)Reference0.543 No24 (4.6%)10 (3.9%)14 (5.38%)1.40 [0.61;3.35]Access to sanitary sewer treatment Yes273 (52.7%)140 (54.3%)133 (51.2%)Reference0.535 No245 (47.3%)118 (45.7%)127 (48.8%)1.13 [0.80;1.60]Access to health insurance Yes155 (29.9%)86 (33.3%)69 (26.5%)Reference0.111 No363 (70.1%)172 (66.7%)191 (73.5%)1.38 [0.95;2.02]Do you believe that vaccines can protect yourself and children from serious diseases? Yes496 (95.9%)253 (98.4%)243 (93.5%)Reference0.008 No21 (4.1%)4 (1.56%)17 (6.54%)4.29 [1.55;15.5]Do you believe there are reasons for people not get vaccinated? Yes66 (12.7%)24 (9.30%)42 (16.2%)Reference0.027 No452 (87.3%)234 (90.7%)218 (83.8%)0.53 [0.31;0.91]Has distance, opening hours of the health unit, time needed to get to the health unit, wait at health unit prevented you from getting yourself immunized? Yes119 (23.0%)52 (20.2%)67 (25.8%)Reference0.157 No399 (77.0%)206 (79.8%)193 (74.2%)0.73 [0.48;1.10]Have you ever received or heard negative information about vaccination? Yes391 (75.8%)194 (75.5%)197 (76.1%)Reference0.960 No125 (24.2%)63 (24.5%)62 (23.9%)0.97 [0.65;1.45]What source of information you mostly use to know about vaccination related information? Health care worker/websites or profile of official Health Organizations130 (25.1%)79 (30.6%)51 (19.6%)Reference<0.001 Traditional News (official website or television)232 (44.8%)126 (48.8%)106 (40.8%)1.30 [0.84;2.02] Social media120 (23.2%)41 (15.9%)79 (30.4%)2.97 [1.78;5.01] Others (friends, neighbours, or none)36 (7.0%)12 (4.7%)24 (9.2%)3.06 [1.42;6.89]Have you ever been advised by health professionals about vaccination? Yes392 (75.8%)195 (75.6%)197 (76.1%)Reference0.977 No117 (22.6%)59 (22.9%)58 (22.4%)0.97 [0.64;1.47] Do not know/do not remember8 (1.6%)4 (1.6%)4 (1.5%)0.99 [0.22;4.45]What is your relationship between yourself and the health care workers from the Health Unit you attend? Great/Good361 (69.7%)187 (72.5%)174 (66.9%)Reference0.314 Reasonable/Indifferent76 (14.7%)38 (14.7%)38 (14.6%)1.07 [0.65;1.77] Bad30 (5.8%)11 (4.5%)19 (7.3%)1.84 [0.86;4.14] Do not attend any health care Unit51 (9.9%)22 (8.5%)29 (11.2%)1.41 [0.78;2.58] Study data according to the occurrence of vaccine hesitancy. Regarding access to health units with vaccination facilities and the availability of vaccines in these locations, 23.0% (119/518) of the respondents reported barriers. Most of the mentioned reasons were related to the lack of vaccines (63/119; 52.9%) and the waiting time at the health unit (50/119; 42.0%). Other reasons for not getting vaccinated in the recommended schedule were reported by 6.2% (32/518) of the participants, as medical counterindication to get vaccinated due to illness or allergies, lack of professionals, lack of support to get to the health unit, bad reception in the health unit, and refusal of the professionals to vaccinate them. A large percentage of respondents affirmed to have had received guidance from health professionals about vaccination (392/518; 75.8%). Regarding the relationship with health professionals, most of the participants had a great or good relationship with the health professionals and workers from the attended health unit (367/518; 69.7%). Over half of the respondents (71.8%, 372/518) said to believe that most people who live with them have themselves vaccinated with all the recommended vaccines. And 77.6% (402/518) reported to not have changed their beliefs after the beginning of the pandemic of COVID-19. However, the HP had a greater percentage of respondents who believed that most people who live with them do not get vaccinated as recommended by the PNI (28.9%, 75/260) when compared to the NHP (19.8, 51/258) with difference between groups (p = 0.020). The majority of respondents did not believe that there are reasons for not vaccinating people in the community (87.3%. 452/518). Nonetheless, the HP had a greater percentage of participants who did believe in reasons for not vaccinating the population (16.2%, 42/260) when compared to the NHP (9.3%, 24/258) (p = 0.027). A greater percentage of the HP also reported to have developed this belief after the onset of the pandemic of COVID-19 (50.0%, 21/42) (p = 0.035). The reasons reported by the NHP for the non-vaccination of the community were mainly related to medical counterindication and illnesses (66.7%, 16/24) whilst, among the HP, the reasons described were the lack of safety in the vaccination and the short time for its development (35.7%, 15/42) and the freedom for the individual choice (28.6%, 12/42). As to other aspects related to the community’s vaccination, almost half the participants did not believe there were difficulties for ethnical or religious groups in the community to get vaccinated (49.6%, 257/518). Of the 28.2% (146/518) that reported difficulties from those groups to get vaccinated, the main reason described was the self-choice to not get vaccinated (62.3%, 104/167), and 21.6% of those reasons were related to the lack of active research for those communities by the health units (36/167.). The great majority of participants reported having never experienced any community leader discouraging vaccination (81.1%, 420/518). The most reported leaders who discouraged vaccination were religious leaders (54.6%, 30/55) and politicians (20.0%, 11/55). Among the study participants, 50,2% (260/518) reported to have hesitated to get one or more vaccines. Among the hesitant respondents, 62.9% (127/260) hesitated to vaccinate only after the beginning of the COVID-19 pandemic. In total, 19.7% (102/518) have refused to get vaccinated, and 56.9% (58/102) of the respondents who refused to get vaccinated with one or more vaccines have refused after the beginning of the COVID-19 pandemic. The most hesitated vaccine were the COVID-19 vaccines (144/260; 55.4%), followed by the influenza vaccine (48/260; 18.5%). Other mentioned vaccines were DTP or DTP (27/260; 10.38%), Hepatitis B (12/260; 4.61%), meningitis (9/260; 3.46%), yellow fever (8/260; 3.07%), MMR (7/260; 2.69%), BCG (5/260; 1.92%), pneumococcal (4/260; 1.53%), IPV or OPV (2/260; 0.76%) vaccines. Among the hesitant respondents, 87 participants (87/260; 33.5%) reported to have delayed their vaccination schedule or to have not been vaccinated for a long time. Most of them informed to not recall which immunizers were out of date, to no longer hold their immunization booklet, or to not remember where it was kept. Regarding reasons for hesitancy, over half were related to lack of confidence (162/260; 62.3%), and all of those were reported to have occurred after the onset of the COVID-19 pandemic. The low perception of safety or worries related to side effects were the most prevalent reason for lack of confidence (92/162; 56.8%), followed by the low perception of efficacy of the vaccine (68/162; 42.0%) and to have read or listened to negative news about the vaccine in various types of media (57/162; 35.2%). Other reasons for hesitation were related to complacency (115/260; 42.7%). The perception that the vaccination was not necessary (72/115; 62.6%), forgetting the date of the vaccine shot (35/115; 30.4%), and demotivation or laziness (13/115; 11.3%) were the main complacency motives informed, but, among those, only the perception that the vaccine was not needed was reported mainly due to the pandemic, moreover, other less mentioned reasons, such as political (4/115; 3.5%) and religious reasons (4/115; 4.4%) were also reported mostly because of the pandemic. Regarding the lack of convenience (93/260; 35.8%), 50.5% (47/93) could not get vaccinated because of their work schedule, and 32.3% (30/93) reported difficulties in finding reliable information about the hesitated vaccines, which was mostly given to the pandemic (Fig 1). Reasons for hesitation according to the 3C conceptual model of determinants of vaccination hesitancy. When comparing hesitant participants (HP) to non-hesitant ones, the HP was younger than the NHP (p < 0.001). When compared to the NHP, the hesitant participants believed less in the ability of vaccines to protect themselves and children from serious illnesses (p = 0.008). Among those who believed that there were reasons for people to not get vaccinated, the HP was the majority (p = 0.027). The HP and NHP got informed about vaccination mostly through television, however, the HP also used social media as the main source of information or did not get actively informed about the topic, while the NHP got more informed through health care professionals or organizations (p < 0.001). The covariates that remained in the final logistic regression model were: mean age, having access to health insurance, positive answer to “vaccines can protect you and children from serious illnesses”, believing there are reasons for people not getting vaccinated, having difficulties accessing vaccines and vaccination services, getting informed mainly through health care professionals, or through social media, or through other sources (friends, family or not getting informed about vaccination at all). Among these covariates, the mean age was significantly negatively associated with hesitancy. In the age-stratified analysis, individuals aged 52–71 showed lower levels of hesitancy (OR = 0.59; 95%CI = 0.36–0.95; p = 0.031) compared with other age groups (Table B in S2 Appendix). Believing that vaccines can protect oneself and children had a moderated negative association with hesitancy. Getting informed mainly through social media had a positive moderated association with hesitancy. The other variables showed no significant association with the increase in vaccine hesitancy, but they contributed to the fitting of the best model. The p-value for the Hosmer and Lemeshow test was 0.485, showing a good model adjustment (Table 2). 10.1371/journal.pone.0348412.t002Table 2The final model for the occurrence of vaccine hesitancy.Covariatesβ Coefficient (SE)aOR (95% CI)Intercept2.68 (0.70)14.82 (2.04; 66.69)Age− 0.01** (0.00)0.98 (0.97; 0.99)“Do you believe that vaccines can protect yourself and children from serious diseases?” (Yes)− 1.46* (0.59)0.23 (0.06; 0.66)Main source of information about vaccination (Health care worker/websites or profile of official Health Organizations)− 0.93* (0.40)0.39 (0.17; 0.86)Main source of information about vaccination (social media)0.04 (0.41)1.03 (0.45; 2.30)Main source of information about vaccination (Traditional media: online and television journals)− 0.59 (0.39)0.55 (0.25; 1.17)Legend: SE: Standard Error; aOR: adjusted odds ratio; CI: confidence interval.*p-value < 0.05; **p-value < 0.01. The final model for the occurrence of vaccine hesitancy. Legend: SE: Standard Error; aOR: adjusted odds ratio; CI: confidence interval. *p-value < 0.05; **p-value < 0.01. Discussion This study observed a high prevalence of vaccine hesitancy among participants, higher than that found in other studies conducted in the country and in countries with similar health systems before the COVID-19 pandemic [18,19]. This result highlights not only the possible impact of the pandemic on vaccination hesitancy in the country, compared to the pre-pandemic era, but also the higher hesitancy compared to other countries with similar universal health systems. Regarding VH in Latin American countries, most studies took place in Brazilian municipalities. Most studies developed abroad, however, don’t address general adult vaccination; instead, they investigate specific vaccine-hesitation, focusing on pregnant women and the elderly population. Nevertheless, COVID-19 vaccine hesitancy has been largely studied. In a scope review of COVID-19-specific hesitation in Africa and Latin America, the highest percentage of hesitancy was 67.2% in Egypt and 73.0% in Ecuador, higher than the percentage of hesitation observed in our study (27.8% of the total population). Anyhow, the lack of homogeneity in the methodology of studying this phenomenon in Latin American and African populations underscores the need for further understanding of the vaccination hesitancy in the global south. The association between age and hesitancy was also identified in other studies [18,20]. This phenomenon is described in the literature as the paradox of immunization, experienced among younger individuals who exhibit more complacent behaviour due to a lack of memory of epidemics and pandemics in their lifetime [21,22]. This was further supported by our age-stratified analysis, in which participants aged 52–71 years showed lower hesitancy compared with younger individuals. Other contextual determinants related to vaccination hesitancy, particularly regarding COVID-19 vaccination, were described in two systematic reviews, where factors such as being female, non-white, having lower income, and lower education levels were determinants of higher vaccination hesitancy [23,24]. This profile is similar to that found in our study. Although variables other than age were not related to vaccine hesitancy, the absence of association underscores the importance of exploratory and periodic studies on factors related to hesitancy. COVID-19 vaccine-specific hesitancy was higher in our study compared to other studies conducted in the country [25,26]. Our study collected data through face-to-face interviews, which may have contributed to the higher prevalence of COVID-19-specific vaccine hesitancy observed. During the pandemic, many studies used online data collection methods, potentially limiting the participation of lower-income individuals and leading to an under-representation of hesitancy rates in the country [27]. The distrust related to the COVID-19 vaccine may be linked to and exacerbated by the COVID-19 infodemic [28]. The reduction in social contact due to social distancing has increased global screen time, leading to increased searches for information about vaccines amid the growing production of misinformation and disinformation regarding COVID-19 vaccines on various social platforms [29,30]. Despite the continued general recognition of the importance of vaccination observed in our study, confidence and feelings of collective responsibility may have diminished due to the pandemic [31,32]. Therefore, the HP in our study may have been more influenced by negative information about vaccines than the NHP. This result may be due to the increasing amount of unverified and negative online information during the pandemic, which may have intensified negative feelings toward the vaccines among these respondents, as observed in other studies [33,34]. Regarding influenza vaccine-specific hesitancy, other studies across the country found similarly low hesitancy, especially among the elderly population, who are the main target of vaccination campaigns [35,36]. This may be due to the widespread diffusion of the National Immunization Program (PNI) influenza immunization campaigns targeting the population annually [37]. Other reasons related to complacency, as reported by the participants, may be linked to the paradoxical success of vaccination, as described previously and recently observed with COVID-19 booster doses [38]. Some authors also report that complacent determinants are driven by the neoliberal system widely spread across the globe [39,40]. Neoliberalism stands for the 70’s renewing of Adam Smith’s liberalism, which defended minimal government intervention and rolling over economic matters, to grow the market [41]. Individualism, free market solutions through privatization, decentralization, and deregulation are pillars of the neoliberal mindset, increasingly incorporated in the rhetorical arguments of vaccine reluctant or hesitant advocates [39]. Forgetting about the vaccination [42,43] and not recording specific hesitated vaccines are described here as hesitation-related behaviors. Forgetfulness may result from a prioritization process where certain tasks are deemed more important than others, leading to the neglect of less prioritized tasks [44,45]. Methods for recalling vaccination doses, especially for long intervals between doses in adult and adolescent vaccination schedules, may be useful for increasing vaccination rates [46]. In addition, the association between risk perception and vaccination behavior has been well established in the scientific literature. Risk perception is commonly described as comprising three dimensions: the perceived likelihood of harm, perceived individual vulnerability to the hazard, and perceived severity of its consequences. Accordingly, higher levels of risk perception are associated with greater vaccine uptake [47]. Based on this framework, we hypothesize that complacent adults’ management of their own vaccination may be partly explained by lower levels of perceived risk within this population. The negative view towards mandatory vaccination found among the participants has been previously described in the Brazilian population and in some European countries [48,49]. This perception must be addressed, especially considering that the political scenario in Brazil may have influenced public opinion about vaccination during the pandemic [50]. The perception that most people who lived with the HP (friends, family, and neighbours) did not get vaccinated with all recommended vaccines evokes discussions about vaccination as a social norm. As an intrinsically social process, individual vaccination can influence not only vaccination coverage but also the behavior of other individuals within social circles as a social norm [51]. Therefore, valuing patients and communities who get vaccinated may enhance vaccination uptake among relatives, friends, and neighbours, and strengthen resilience against anti-vaccine sentiments [51]. Despite the low prevalence of obstacles to vaccination, the lack of vaccines and other access difficulties have been described in previous literature in the Global South and in Brazil [52,53]. However, this issue appears to be more related to a shortage of vaccines during the pandemic, which was a global occurrence. During the pandemic, the expectation that Brazil would be an independent source to supply itself and other Latin American countries did not materialize, highlighting the country’s lack of self-sufficiency in vaccine manufacturing during a public health emergency [54]. Regarding the good relationship with healthcare professionals among the participants in our study, healthcare professionals are the most important and reliable source of information about vaccination, and they play a crucial role in enhancing health literacy among the population [55]. In recent years, primary healthcare attention has been strengthened in Brazil, which may have improved the study population’s perception of healthcare. Nevertheless, the strengthening of the patient-healthcare professional is crucial to decrease hesitancy in the studied population. The development of strategies to quickly respond to health emergencies that may decrease vaccine uptake, with honesty and transparency, to enhance popular trust in the health system [56]. The use of traditional mass media, such as television, in combination with educational interventions, has been shown to improve perceptions of vaccination. At the same time, the widespread influence of social media and other digital communication technologies underscores the need for these platforms to be strategically incorporated into vaccination promotion and advocacy within healthcare system [57]. Our findings should be interpreted within a broader context of risk perception, institutional trust, and health communication. The WHO SAGE Working Group has emphasized that vaccine hesitancy is shaped not only by individual beliefs but also by perceived risk, confidence in health authorities, and the credibility of information disseminated to the public [10] (WHO, 2014). International evidence supports this perspective, as a global survey across 67 countries demonstrated substantial variation in vaccine confidence, with institutional trust and political context playing a particularly important role in middle-income settings [58]. During the COVID-19 pandemic, the World Health Organization further highlighted the emergence of an “infodemic,” in which the rapid spread of misinformation through social and traditional media challenged effective risk communication and public adherence to health recommendations [59]. Although our study was not designed to directly assess political determinants or exposure to misinformation, the observed associations between vaccine hesitancy, younger age, and reliance on non-institutional information sources are consistent with this broader literature, underscoring the importance of strengthening trustworthy health communication and institutional credibility. Our study has some limitations, including a sample that may not accurately represent the city’s true demographics. Specifically, there was an underrepresentation of teenagers and an overrepresentation of the elderly compared to the actual population of Campo Grande. Additionally, there were few participants per household, and access to wealthier residents was restricted due to entry denial into gated communities and apartment buildings. Nevertheless, few studies have comprehensively addressed vaccination hesitancy across all vaccines and included a wide age range during the transition towards the end of the COVID-19 pandemic. Furthermore, our study was conducted through face-to-face interviews, potentially biasing towards a higher representation of the lower-income population in Campo Grande. Conclusions We observed a high prevalence of vaccine hesitancy in Campo Grande, likely exacerbated by the COVID-19 pandemic and infodemic, which have contributed to heightened negative perceptions of vaccines. While access barriers were noted to a lesser extent, they remain significant for achieving adequate vaccination coverage. Additionally, complacency and forgetfulness regarding vaccination importance may also impact vaccination rates in the municipality. Addressing these challenges at both individual and community levels is crucial. Effective use of technology for communication and combating misinformation is essential. Furthermore, promoting health education to enhance individual autonomy and community resilience is key to countering current and future anti-vaccine movements. Supporting information Sampling strategy and sample size calculation using the WHO two-stage cluster sampling method. (PDF) Analysis of vaccine hesitancy by age groups (20-year intervals): descriptive comparisons and multivariable logistic regression. (PDF) Data collection instrument: adapted WHO SAGE questionnaire, additional variables, and 3C model framework for vaccine hesitancy. (PDF) 11 Dec 2025 -->PONE-D-25-13866-->-->Age and Vaccine Information Sources Drive Vaccine Hesitancy: A Household Survey in Central-Western Brazil-->-->PLOS One Dear Dr. Falcão de Oliveira, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The reviewers provided valuable and consistent feedback, highlighting the relevance of the topic and the potential contribution of this manuscript to the literature on vaccine hesitancy in Brazil and the Global South. The paper would benefit from further methodological clarification, conceptual precision, and a more parsimonious statistical presentation. In revising the manuscript, the authors should include a clear justification for the sampling calculations, preferably in an appendix, detailing the assumptions and parameters employed. The rationale for selecting Campo Grande as the study site must also be expanded, explaining how this case contributes to understanding the broader research problem, particularly given its geographical, socioeconomic, and informational specificities. The authors are further encouraged to provide a more detailed description of the cultural adaptation process of the SAGE Work Group Questionnaire for the Brazilian context, ensuring the validity and comparability of the instrument. The operational definitions of hesitant participants (HP) and non-hesitant participants (NHP) should be clarified to reinforce analytical transparency. In the statistical section, a more concise and parsimonious presentation of the bivariate models is recommended, with non-essential details moved to supplementary materials. Throughout the discussion, speculative formulations such as “may have” or “maybe” should be avoided to maintain a scientific tone and restrict interpretations to what the evidence allows to be demonstrated. Finally, the reference to the “neoliberal system” introduced in the discussion requires conceptual elaboration, since the term is not developed elsewhere in the manuscript. Defining it succinctly and connecting it to the behavioral and structural determinants of vaccine hesitancy will enhance theoretical coherence. Overall, the manuscript is promising and well-grounded empirically. Addressing these points will strengthen the methodological robustness, analytical precision, and international relevance of the journal, aligning it more closely with PLOS ONE’s standards. Please submit your revised manuscript by Jan 25 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:--> A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ivan Filipe de Almeida Lopes Fernandes, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating the following in the Competing Interests section: I have read the journal’s policy and the authors of this manuscript have the following competing interests: EFO is an Academic Editor of PLOS ONE. Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. 3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 4. We note that your Data Availability Statement is currently as follows: All relevant data are within the manuscript and its Supporting Information files. Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. 5. Please include a separate caption for each figure in your manuscript. 6. We note that Figure 1 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright We require you to either (a) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (b) remove the figures from your submission: a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an ""Other"" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ 7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: The reviewers provided valuable and consistent feedback, highlighting the relevance of the topic and the potential contribution of this manuscript to the literature on vaccine hesitancy in Brazil and the Global South. The paper would benefit from further methodological clarification, conceptual precision, and a more parsimonious statistical presentation. In revising the manuscript, the authors should include a clear justification for the sampling calculations, preferably in an appendix, detailing the assumptions and parameters employed. The rationale for selecting Campo Grande as the study site must also be expanded, explaining how this case contributes to understanding the broader research problem, particularly given its geographical, socioeconomic, and informational specificities. The authors are further encouraged to provide a more detailed description of the cultural adaptation process of the SAGE Work Group Questionnaire for the Brazilian context, ensuring the validity and comparability of the instrument. The operational definitions of hesitant participants (HP) and non-hesitant participants (NHP) should be clarified to reinforce analytical transparency. In the statistical section, a more concise and parsimonious presentation of the bivariate models is recommended, with non-essential details moved to supplementary materials. Throughout the discussion, speculative formulations such as “may have” or “maybe” should be avoided to maintain a scientific tone and restrict interpretations to what the evidence allows to be demonstrated. Finally, the reference to the “neoliberal system” introduced in the discussion requires conceptual elaboration, since the term is not developed elsewhere in the manuscript. Defining it succinctly and connecting it to the behavioral and structural determinants of vaccine hesitancy will enhance theoretical coherence. Overall, the manuscript is promising and well-grounded empirically. Addressing these points will strengthen the methodological robustness, analytical precision, and international relevance of the journal, aligning it more closely with PLOS ONE’s standards. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** -->2. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** -->3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: No Reviewer #2: Yes Reviewer #3: No ********** -->4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** -->5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: Dear Editor, I consider the topic relevant and current, with important repercussions for discussions regarding vaccine hesitancy, non-vaccination, and refusal. Furthermore, it presents a careful critique of the shortcomings in access to vaccines through health services. The text is quite thought-provoking, simple, and harmonious, motivating reading without causing fatigue or difficulty in interpretation. The study aims to measure vaccine hesitancy and its associated factors among residents of Campo Grande, the capital of the state of Mato Grosso do Sul, Brazil. This is a very important topic for current discussions regarding vaccination coverage, which has been declining in the country, where the Immunization Program is powerful and recognized as one of the best in the world. The authors very well justify the importance of conducting the study and, of course, publishing the results, which makes it reasonable to consider its publication in a journal like PlosOne as timely. Regarding materials and methods The authors state that this is a cross-sectional study, aligned with a household survey conducted in Campo Grande to estimate vaccination coverage in the municipality, with data collected between September 2022 and October 2023. In this section, I initially had doubts regarding the methodology; it wasn't entirely clear that this article is part of the results of the household survey (also conducted by them?) used for a different purpose (to estimate vaccination coverage). By stating in the first part of this section that the objective was to estimate vaccination coverage, the initial impression is that there was a change in the objective of the work. I believe a small correction will make the text clearer. Regarding the study population and data collection, the methodology employed is very well described, allowing for the replication of the study for both sampling and survey application. The statistical analysis employed is also appropriate for the purpose of the study. The results were presented clearly, and the discussion considered previous studies showing possible comparisons. Reviewer #2: The article presents a theme of significant importance for public health, as it examines health vulnerability within diverse social contexts. The research displays appropriate scientific rigor and complies with ethical requirements. I endorse its publication. Reviewer #3: This manuscript addresses a highly relevant and policy-sensitive topic—vaccine hesitancy—in the Brazilian context. The dataset is valuable, and the survey is methodologically sound, offering potential for a meaningful contribution to global public health discussions. However, to meet the standards expected in a high-impact international journal such as PLOS ONE, the paper requires major revisions in several areas of structure, contextualization, and theoretical framing. 1. Literature Review and Theoretical Framework The literature review is currently too narrow and must be substantially expanded. While the 3C and 5C models are important conceptual tools for understanding vaccine hesitancy, the manuscript should also engage with other established frameworks in the health and behavioral sciences. Classic public health literature has long discussed the trade-off between self-protection and vaccination, noting that in periods of lower perceived risk, individuals tend to vaccinate less—a phenomenon well documented before the COVID-19 era. The authors should also incorporate literature on risk perception, behavioral economics, and health communication, as well as the political economy of vaccination in contexts of misinformation and institutional fragmentation. The Brazilian case is particularly relevant here, as federal authorities—including the former president—publicly questioned vaccination and containment measures, contributing to public confusion. This political dimension must be reflected and supported with appropriate scholarly references. 2. Contextualization of the Brazilian Case Brazil has one of the world’s most longstanding and successful immunization programs, established in the 1970s during the military regime, which achieved major public health milestones through strong coordination, communication, and outreach. The authors should discuss: The historical trajectory of the National Immunization Program (PNI) and its role in shaping public trust. The recent decline in vaccination coverage since 2016, linked to fiscal constraints and reduced federal investment in vaccination campaigns. The loss of public health communication capacity—propaganda, media campaigns, and health education—which used to sustain confidence in vaccines. Campo Grande should also be contextualized geographically and socioeconomically. How representative is this municipality within Brazil’s continental diversity? Is it a border region influenced by migration, poverty, or digital misinformation networks? 3. Data Presentation and Statistical Rigor The paper presents interesting results, but it lacks sufficient statistical detail and transparency. The authors should: Include appendices or supplementary materials with the full survey instrument, descriptive tables, and regression outputs. Explore heterogeneity across age groups, given that older generations experienced robust vaccination programs, while younger individuals were socialized in an era of digital disinformation. Discuss how social media usage patterns and regional political contexts might interact with hesitancy. Including a map or stratification by clusters could strengthen the empirical contribution. 4. Discussion and Policy Implications The discussion needs to move beyond description. The authors should draw clearer policy lessons from their findings—how public health systems can rebuild confidence, counter misinformation, and restore vaccination coverage. Comparative insights from other Latin American or Global South contexts could make the paper more internationally relevant. The authors could also explore policy alternatives, such as communication strategies, digital literacy programs, and targeted outreach to younger populations. 5. Overall Assessment The study is promising and empirically rich, but its current framing makes it read more as a localized case study than as a paper contributing to global public health theory. With a deeper theoretical engagement, a stronger connection to Brazil’s historical and political context, and a clearer presentation of data, the manuscript has real potential to make an important contribution to the literature on vaccine hesitancy, health communication, and pandemic governance. ********** -->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. 4 Feb 2026 Editor’s comments In revising the manuscript, the authors should include a clear justification for the sampling calculations, preferably in an appendix, detailing the assumptions and parameters employed. The rationale for selecting Campo Grande as the study site must also be expanded, explaining how this case contributes to understanding the broader research problem, particularly given its geographical, socioeconomic, and informational specificities. The authors are further encouraged to provide a more detailed description of the cultural adaptation process of the SAGE Work Group Questionnaire for the Brazilian context, ensuring the validity and comparability of the instrument. The operational definitions of hesitant participants (HP) and non-hesitant participants (NHP) should be clarified to reinforce analytical transparency. In the statistical section, a more concise and parsimonious presentation of the bivariate models is recommended, with non-essential details moved to supplementary materials. Throughout the discussion, speculative formulations such as “may have” or “maybe” should be avoided to maintain a scientific tone and restrict interpretations to what the evidence allows to be demonstrated. Finally, the reference to the “neoliberal system” introduced in the discussion requires conceptual elaboration, since the term is not developed elsewhere in the manuscript. Defining it succinctly and connecting it to the behavioral and structural determinants of vaccine hesitancy will enhance theoretical coherence. Overall, the manuscript is promising and well-grounded empirically. Addressing these points will strengthen the methodological robustness, analytical precision, and international relevance of the journal, aligning it more closely with PLOS ONE’s standards. Author response: We thank the Editor for their comments and suggestions, which substantially enhanced the overall quality of the manuscript. All recommendations were fully addressed. An S1 Appendix detailing the sampling justification and methodology was uploaded alongside the data questionnaire. Nevertheless, we maintained a cautious use of language indicating possibility, given the methodological design of our work, which does not allow causal inferences beyond hypothesis generation for future research. In addition, a definition for the neoliberal system was included in the manuscript (page 18, lines 378 - 382) Reviewer #1 Regarding materials and methods The authors state that this is a cross-sectional study, aligned with a household survey conducted in Campo Grande to estimate vaccination coverage in the municipality, with data collected between September 2022 and October 2023. In this section, I initially had doubts regarding the methodology; it wasn't entirely clear that this article is part of the results of the household survey (also conducted by them?) used for a different purpose (to estimate vaccination coverage). By stating in the first part of this section that the objective was to estimate vaccination coverage, the initial impression is that there was a change in the objective of the work. I believe a small correction will make the text clearer. Author response: Thank you for this observation. We acknowledge that the original wording may have lacked clarity and could have led to confusion regarding the methodology. We have revised the paragraph to clearly describe the household survey design and its alignment with the objective of assessing vaccine hesitancy. The revised text now reads as follows: “This cross-sectional study used data collected through a household survey conducted in Campo Grande, Mato Grosso do Sul, Brazil, between September 2022 and October 2023, with the primary objective of estimating vaccination coverage in the municipality. For the purposes of this analysis, data on vaccine hesitancy were also collected and analyzed”. Regarding the study population and data collection, the methodology employed is very well described, allowing for the replication of the study for both sampling and survey application. The statistical analysis employed is also appropriate for the purpose of the study. The results were presented clearly, and the discussion considered previous studies showing possible comparisons. Author response: We thank Reviewer #1 for their constructive comments and careful review of the manuscript. Reviewer #2 The article presents a theme of significant importance for public health, as it examines health vulnerability within diverse social contexts. The research displays appropriate scientific rigor and complies with ethical requirements. I endorse its publication. Author response: We thank Reviewer #2 for their constructive comments and careful review of the manuscript. Reviewer #3 1. Literature Review and Theoretical Framework The literature review is currently too narrow and must be substantially expanded. While the 3C and 5C models are important conceptual tools for understanding vaccine hesitancy, the manuscript should also engage with other established frameworks in the health and behavioral sciences. Classic public health literature has long discussed the trade-off between self-protection and vaccination, noting that in periods of lower perceived risk, individuals tend to vaccinate less—a phenomenon well documented before the COVID-19 era. Author response: We thank the reviewer for this comment and acknowledge the importance of broader theoretical frameworks in the study of vaccine hesitancy. Nevertheless, the manuscript intentionally focuses on the 3C model, as this framework directly underpins the WHO-recommended instrument used for data collection and analysis. While the 5C model is conceptually relevant, it was proposed after the development of the questionnaire applied in this study and is therefore addressed only in the discussion where appropriate. This approach was adopted to preserve theoretical consistency and maintain focus on the study’s central research question. To address the reviewer’s comment, we have added a paragraph to the Discussion section addressing the literature on risk perception (page 18, lines 389 – 396). The authors should also incorporate literature on risk perception, behavioral economics, and health communication, as well as the political economy of vaccination in contexts of misinformation and institutional fragmentation. The Brazilian case is particularly relevant here, as federal authorities—including the former president—publicly questioned vaccination and containment measures, contributing to public confusion. This political dimension must be reflected and supported with appropriate scholarly references. Author response: We agree and thank the reviewer for highlighting the relevance of risk perception, health communication, and political-institutional contexts in shaping vaccine-related attitudes. In response to this comment, we have added a paragraph to the Discussion section situating our findings within the literature on risk perception and health communication, drawing on the WHO SAGE framework and international evidence on vaccine confidence (page 20, lines 430 – 445). This includes references to how political and institutional contexts may influence public trust, as documented in comparative studies across high- and middle-income countries. Given the cross-sectional design and the scope of the WHO-recommended survey instrument used in this study, these aspects are discussed as contextual factors rather than primary analytical determinants, in order to avoid causal interpretations not supported by the data. 2. Contextualization of the Brazilian Case Brazil has one of the world’s most longstanding and successful immunization programs, established in the 1970s during the military regime, which achieved major public health milestones through strong coordination, communication, and outreach. The authors should discuss: The historical trajectory of the National Immunization Program (PNI) and its role in shaping public trust. The recent decline in vaccination coverage since 2016, linked to fiscal constraints and reduced federal investment in vaccination campaigns. The loss of public health communication capacity—propaganda, media campaigns, and health education—which used to sustain confidence in vaccines. Campo Grande should also be contextualized geographically and socioeconomically. How representative is this municipality within Brazil’s continental diversity? Is it a border region influenced by migration, poverty, or digital misinformation networks? Author response: We included a brief description of the development of the Brazilian Immunization Program (page 3, lines 44 – 62), and also described important characteristics of the municipality of Campo Grande in the Methods section (page 5, lines 105 – 115). 3. Data Presentation and Statistical Rigor The paper presents interesting results, but it lacks sufficient statistical detail and transparency. The authors should: Include appendices or supplementary materials with the full survey instrument, descriptive tables, and regression outputs. Explore heterogeneity across age groups, given that older generations experienced robust vaccination programs, while younger individuals were socialized in an era of digital disinformation. Discuss how social media usage patterns and regional political contexts might interact with hesitancy. Including a map or stratification by clusters could strengthen the empirical contribution. Author response: We appreciate the feedback and considered all of it during the manuscript review. S2 and S3 Appendices detailing the methodology, including the data analysis, were included in the revised version of the manuscript. Regarding heterogeneity across age groups, our data already support a generational interpretation, as hesitant participants were, on average, younger than non-hesitant individuals (mean = 43.8 years [SD = 16.3] vs. mean = 49.6 years [SD =18.0]). This pattern suggests an age gradient consistent with generational differences rather than an abrupt threshold effect, supporting the use of age as a continuous variable in the main analysis while allowing for interpretative discussion of generational dynamics. To address the reviewer’s comment and explore heterogeneity across age groups, we conducted additional descriptive analyses stratified by age categories, while retaining age as a continuous variable in the main regression model to preserve statistical power and avoid arbitrary cutoffs. 4. Discussion and Policy Implications The discussion needs to move beyond description. The authors should draw clearer policy lessons from their findings—how public health systems can rebuild confidence, counter misinformation, and restore vaccination coverage. Comparative insights from other Latin American or Global South contexts could make the paper more internationally relevant. The authors could also explore policy alternatives, such as communication strategies, digital literacy programs, and targeted outreach to younger populations. Author response: We appreciate the reviewer’s suggestion and have incorporated a paragraph aimed at contributing to public health policies. We also included a brief paragraph regarding the lack of studies developed on general vaccination and discussed our vaccine hesitancy percentage compared to other LATAM studies. 5. Overall Assessment The study is promising and empirically rich, but its current framing makes it read more as a localized case study than as a paper contributing to global public health theory. With a deeper theoretical engagement, a stronger connection to Brazil’s historical and political context, and a clearer presentation of data, the manuscript has real potential to make an important contribution to the literature on vaccine hesitancy, health communication, and pandemic governance. Author response: We thank the thoughtful analysis of our work, and hopefully, the changes applied will highlight the importance of publications regarding vaccine hesitancy Submitted filename: Response to Reviewers.docx 15 Apr 2026 Age and Vaccine Information Sources Drive Vaccine Hesitancy: A Household Survey in Central-Western Brazil PONE-D-25-13866R1 Dear Dr. Falcão de Oliveira, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ivan Filipe de Almeida Lopes Fernandes, Ph.D. Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #3: All comments have been addressed ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #3: Yes ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #3: Yes ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #3: Yes ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #3: Yes ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #3: I am satisfied. TThe authors addressed all comments. Congratularions. I hope to see the paper soon published. ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #3: Yes:GUSTAVO ANDREY DE ALMEIDA LOPES FERNANDES ********** PONE-D-25-13866R1 PLOS One Dear Dr. Falcão de Oliveira, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ivan Filipe de Almeida Lopes Fernandes Academic Editor PLOS One